ArticleEmerging infectious diseases2017
Incidence and Characteristics of Scarlet Fever, South Korea, 2008-2015.
Article in Emerging infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Epidemiological characteristics and spatiotemporal analysis of scarlet fever in Guangzhou, China: the surveillance of 20 years.BMC infectious diseases · 2026Article
- The role of school terms in the epidemics of scarlet fever among pre-school-aged and school-aged children: a 15-year population-based surveillance in China.BMC public health · 2026Article
- Contact Patterns Drive Age-Structured Transmission Dynamics and Seasonality of Scarlet Fever.Pathogens (Basel, Switzerland) · 2026Article
- Scarlet fever and meteorological exposures in Jiangsu, China: a time-stratified case-crossover study.BMC public health · 2025Article
- Epidemiology of scarlet fever in Victoria, Australia, 2007-2017.Epidemiology and infection · 2024Article
- Epidemiological changes of scarlet fever before, during and after the COVID-19 pandemic in Chongqing, China: a 19-year surveillance and prediction study.BMC public health · 2024Article
- Review
- Early Warning and Prediction of Scarlet Fever in China Using the Baidu Search Index and Autoregressive Integrated Moving Average With Explanatory Variable (ARIMAX) Model: Time Series Analysis.Journal of medical Internet research · 2023Article
- Patterns in the Incidence of Scarlet Fever Among Children Aged 0-9 Years - China, 2010-2019.China CDC weekly · 2023Article
- Pathogenesis, epidemiology and control of Group A Streptococcus infection.Nature reviews. Microbiology · 2023Review
- Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group AOpen forum infectious diseases · 2023Article
- Insertion of an immunodominant T helper cell epitope within the Group AFrontiers in immunology · 2023Article
- The dynamics of scarlet fever in The Netherlands, 1906-1920: a historical analysis.Royal Society open science · 2022Article
- Collateral Impact of COVID-19 Prevention Measures on Re-Emergence of Scarlet Fever and Pertussis in Mainland China and Hong Kong China.International journal of environmental research and public health · 2022Article
- Epidemiological trend in scarlet fever incidence in China during the COVID-19 pandemic: A time series analysis.Frontiers in public health · 2022Article
- The association between ambient air pollution and scarlet fever in Qingdao, China, 2014-2018: a quantitative analysis.BMC infectious diseases · 2021Article
- [Epidemiological characteristics of infectious diseases of group A, B and C among Chinese students' population].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2021Article
- Infectious Respiratory Diseases Decreased during the COVID-19 Pandemic in South Korea.International journal of environmental research and public health · 2021Article
- Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group AFrontiers in microbiology · 2021Review
- Incidence and Effects of Acquisition of the Phage-EncodedFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence rate for scarlet fever in South Korea is rising. During 2008-2015, we collected group A Streptococcus isolates and performed emm and exotoxin genotyping and disk-diffusion antimicrobial tests. Scarlet fever in South Korea was most closely associated with emm types emm4, emm28, emm1, and emm3. In 2015, tetracycline resistance started increasing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.